Can Cobalamin prevent Oxaliplatin induced peripheral neuropathy?

Background and objectives:Peripheral neuropathy induced by oxaliplatin is one of the main reasons for discontinuing chemotherapy. In this article, we evaluated the role of vitamin B12 in the prevention of oxaliplatin-induced peripheral neuropathy. Methods: A prospective randomized interventional...

Full description

Saved in:
Bibliographic Details
Main Authors: Naza Shakir Shareef Shekhany, Jangi Shawkat Salai
Format: Article
Language:English
Published: Kurdistan Higher Council Of Medical Specialties 2023-06-01
Series:Advanced Medical Journal
Subjects:
Online Access:https://amj.khcms.edu.krd/index.php/main/article/view/242
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850182723298131968
author Naza Shakir Shareef Shekhany
Jangi Shawkat Salai
author_facet Naza Shakir Shareef Shekhany
Jangi Shawkat Salai
author_sort Naza Shakir Shareef Shekhany
collection DOAJ
description Background and objectives:Peripheral neuropathy induced by oxaliplatin is one of the main reasons for discontinuing chemotherapy. In this article, we evaluated the role of vitamin B12 in the prevention of oxaliplatin-induced peripheral neuropathy. Methods: A prospective randomized interventional study was done from 1st January 2018 to 30th De- cember 2018, in which patients who were diagnosed with gastrointestinal cancer in Rizgary and Nanakali teaching hospitals that have been scheduled to receive oxaliplatin-based regimen were enrolled. Patients were divided into two groups: control group received chemotherapy only and prophylaxis group received chemotherapy with vitamin B12; each group included fifteen patients with no significant differences between the groups regarding age and gender. The prophylaxis group received vitamin B12 injection in scheduled periods. All Patients received at least a cumulative dose of 500 mg/m2 of oxaliplatin. Patients were evaluated by nerve conduction study, B12 level, and other laboratory tests. Results: Twenty-one patients completed the study. There was a significant decrease in the serum vitamin B12 level (601.84±398.43 to 363±337.31) post-chemotherapy among the control group. Among the prophylaxis group, the mean value of serum vitamin B12 increased significantly after chemotherapy. To summarize, there was a significant decrease in the amplitude of nerve conduction study in the control group as compared to the prophylaxis group espe- cially in left (11.85±6.84 to 8.14±5.36) and right (14.01±6.05 to 9.52±6.08) Sural nerves. Conclusions:Vitamin B12 injection had an important role in the prevention of development of chronic oxaliplatin-induced peripheral neuropathy.
format Article
id doaj-art-81f2c6479147409ea6657fbd7045fe03
institution OA Journals
issn 2958-8979
2957-3580
language English
publishDate 2023-06-01
publisher Kurdistan Higher Council Of Medical Specialties
record_format Article
series Advanced Medical Journal
spelling doaj-art-81f2c6479147409ea6657fbd7045fe032025-08-20T02:17:34ZengKurdistan Higher Council Of Medical SpecialtiesAdvanced Medical Journal2958-89792957-35802023-06-015210.56056/amj.2019.102243Can Cobalamin prevent Oxaliplatin induced peripheral neuropathy?Naza Shakir Shareef Shekhany0Jangi Shawkat Salai1Department of pharmacology, college of pharmacy, Hawler medical university, Erbil, Iraq.Department of Pharmacology and Biophysics, college of medicine, Hawler medical university, Erbil, Iraq. Background and objectives:Peripheral neuropathy induced by oxaliplatin is one of the main reasons for discontinuing chemotherapy. In this article, we evaluated the role of vitamin B12 in the prevention of oxaliplatin-induced peripheral neuropathy. Methods: A prospective randomized interventional study was done from 1st January 2018 to 30th De- cember 2018, in which patients who were diagnosed with gastrointestinal cancer in Rizgary and Nanakali teaching hospitals that have been scheduled to receive oxaliplatin-based regimen were enrolled. Patients were divided into two groups: control group received chemotherapy only and prophylaxis group received chemotherapy with vitamin B12; each group included fifteen patients with no significant differences between the groups regarding age and gender. The prophylaxis group received vitamin B12 injection in scheduled periods. All Patients received at least a cumulative dose of 500 mg/m2 of oxaliplatin. Patients were evaluated by nerve conduction study, B12 level, and other laboratory tests. Results: Twenty-one patients completed the study. There was a significant decrease in the serum vitamin B12 level (601.84±398.43 to 363±337.31) post-chemotherapy among the control group. Among the prophylaxis group, the mean value of serum vitamin B12 increased significantly after chemotherapy. To summarize, there was a significant decrease in the amplitude of nerve conduction study in the control group as compared to the prophylaxis group espe- cially in left (11.85±6.84 to 8.14±5.36) and right (14.01±6.05 to 9.52±6.08) Sural nerves. Conclusions:Vitamin B12 injection had an important role in the prevention of development of chronic oxaliplatin-induced peripheral neuropathy. https://amj.khcms.edu.krd/index.php/main/article/view/242OxaliplatinOxaliplatin-induced peripheral neuropathyVitamin B12
spellingShingle Naza Shakir Shareef Shekhany
Jangi Shawkat Salai
Can Cobalamin prevent Oxaliplatin induced peripheral neuropathy?
Advanced Medical Journal
Oxaliplatin
Oxaliplatin-induced peripheral neuropathy
Vitamin B12
title Can Cobalamin prevent Oxaliplatin induced peripheral neuropathy?
title_full Can Cobalamin prevent Oxaliplatin induced peripheral neuropathy?
title_fullStr Can Cobalamin prevent Oxaliplatin induced peripheral neuropathy?
title_full_unstemmed Can Cobalamin prevent Oxaliplatin induced peripheral neuropathy?
title_short Can Cobalamin prevent Oxaliplatin induced peripheral neuropathy?
title_sort can cobalamin prevent oxaliplatin induced peripheral neuropathy
topic Oxaliplatin
Oxaliplatin-induced peripheral neuropathy
Vitamin B12
url https://amj.khcms.edu.krd/index.php/main/article/view/242
work_keys_str_mv AT nazashakirshareefshekhany cancobalaminpreventoxaliplatininducedperipheralneuropathy
AT jangishawkatsalai cancobalaminpreventoxaliplatininducedperipheralneuropathy